Back to results
US 2006/0234939 A1Published application
Methods of using ziconotide to treat overactive bladder
AssigneeDynogen Pharmaceuticals, Inc.
InventorsMatthew Fraser, Karl Thor, Edward Burgard
Life of this patent
Estimating the term…
Abstract
The invention relates to methods of using Cav2.2 subunit calcium channel modulators to treat painful and non-painful lower urinary tract disorders and the related genitourinary tract disorders vulvodynia and vulvar vestibulitis in normal and spinal cord injured patients.
Claims14
A method for treating overactive bladder which comprises administering to an individual in need thereof a therapeutically effective amount of an active agent wherein said agent is Ziconotide (ω-conotoxin MVIIA) or a pharmaceutically acceptable salt, ester, amide, prodrug, active metabolite or derivative thereof.
Dependencies are inferred from the claim text.